Cargando…
Alcohol and substance use in pregnancy during the COVID-19 pandemic
BACKGROUND: The impact of the COVID-19 pandemic on alcohol and substance use has been a topic of concern. Pregnant women are currently experiencing elevated anxiety and depression symptoms, which may increase risk of substance use, and potentially result in poor perinatal and neurodevelopmental outc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758579/ https://www.ncbi.nlm.nih.gov/pubmed/34102507 http://dx.doi.org/10.1016/j.drugalcdep.2021.108760 |
_version_ | 1784852070792167424 |
---|---|
author | Kar, Preeti Tomfohr-Madsen, Lianne Giesbrecht, Gerald Bagshawe, Mercedes Lebel, Catherine |
author_facet | Kar, Preeti Tomfohr-Madsen, Lianne Giesbrecht, Gerald Bagshawe, Mercedes Lebel, Catherine |
author_sort | Kar, Preeti |
collection | PubMed |
description | BACKGROUND: The impact of the COVID-19 pandemic on alcohol and substance use has been a topic of concern. Pregnant women are currently experiencing elevated anxiety and depression symptoms, which may increase risk of substance use, and potentially result in poor perinatal and neurodevelopmental outcomes for children. METHODS: Survey results were analyzed from an ongoing study of 7470 pregnant individuals in Canada: Pregnancy during the COVID-19 Pandemic. Participants were asked about current use of alcohol and substances, symptoms of depression and anxiety, and COVID-19 concerns: how much they worry about COVID-19 threatening their baby’s life, threatening their own life, care for themselves or the baby, feelings of social isolation, and financial difficulties. RESULTS: The percentage of participants who reported use during pregnancy was 6.7 % for alcohol, 4.3 % for cannabis, 4.9 % for tobacco, and 0.3 % for illicit drugs; 2.6 % were using multiple substances. Higher depression symptoms and financial difficulties were associated with more cannabis and/or tobacco use as well as the co-use of substances. There were no associations between alcohol use and mental health or COVID-19 concerns. CONCLUSIONS: Self-reported rates of use and co-use were lower or comparable to previous research, perhaps reflecting pandemic-related circumstances or the demographics of this sample. Depression symptoms and pandemic-related financial difficulties were associated with more tobacco use, cannabis use, and substance co-use. It remains important to maintain access to perinatal, mental health, and financial supports during the pandemic to mitigate prenatal alcohol and substance use and prevent poor perinatal and long-term neurodevelopmental outcomes for children. |
format | Online Article Text |
id | pubmed-9758579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97585792022-12-19 Alcohol and substance use in pregnancy during the COVID-19 pandemic Kar, Preeti Tomfohr-Madsen, Lianne Giesbrecht, Gerald Bagshawe, Mercedes Lebel, Catherine Drug Alcohol Depend Article BACKGROUND: The impact of the COVID-19 pandemic on alcohol and substance use has been a topic of concern. Pregnant women are currently experiencing elevated anxiety and depression symptoms, which may increase risk of substance use, and potentially result in poor perinatal and neurodevelopmental outcomes for children. METHODS: Survey results were analyzed from an ongoing study of 7470 pregnant individuals in Canada: Pregnancy during the COVID-19 Pandemic. Participants were asked about current use of alcohol and substances, symptoms of depression and anxiety, and COVID-19 concerns: how much they worry about COVID-19 threatening their baby’s life, threatening their own life, care for themselves or the baby, feelings of social isolation, and financial difficulties. RESULTS: The percentage of participants who reported use during pregnancy was 6.7 % for alcohol, 4.3 % for cannabis, 4.9 % for tobacco, and 0.3 % for illicit drugs; 2.6 % were using multiple substances. Higher depression symptoms and financial difficulties were associated with more cannabis and/or tobacco use as well as the co-use of substances. There were no associations between alcohol use and mental health or COVID-19 concerns. CONCLUSIONS: Self-reported rates of use and co-use were lower or comparable to previous research, perhaps reflecting pandemic-related circumstances or the demographics of this sample. Depression symptoms and pandemic-related financial difficulties were associated with more tobacco use, cannabis use, and substance co-use. It remains important to maintain access to perinatal, mental health, and financial supports during the pandemic to mitigate prenatal alcohol and substance use and prevent poor perinatal and long-term neurodevelopmental outcomes for children. Elsevier B.V. 2021-08-01 2021-05-21 /pmc/articles/PMC9758579/ /pubmed/34102507 http://dx.doi.org/10.1016/j.drugalcdep.2021.108760 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kar, Preeti Tomfohr-Madsen, Lianne Giesbrecht, Gerald Bagshawe, Mercedes Lebel, Catherine Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title | Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title_full | Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title_fullStr | Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title_full_unstemmed | Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title_short | Alcohol and substance use in pregnancy during the COVID-19 pandemic |
title_sort | alcohol and substance use in pregnancy during the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758579/ https://www.ncbi.nlm.nih.gov/pubmed/34102507 http://dx.doi.org/10.1016/j.drugalcdep.2021.108760 |
work_keys_str_mv | AT karpreeti alcoholandsubstanceuseinpregnancyduringthecovid19pandemic AT tomfohrmadsenlianne alcoholandsubstanceuseinpregnancyduringthecovid19pandemic AT giesbrechtgerald alcoholandsubstanceuseinpregnancyduringthecovid19pandemic AT bagshawemercedes alcoholandsubstanceuseinpregnancyduringthecovid19pandemic AT lebelcatherine alcoholandsubstanceuseinpregnancyduringthecovid19pandemic |